Some subgroups exhibit tumor-suppressive effects (notably effector CD3+, cytotoxic CD8+ and memory CD445RO+), while some other subgroups exhibit tumor-supportive effects (regulatory FoxP3+ and immune tolerance PD-1+). This evidence concerns the gene CD8A and neoplasm.